Company / FCF Margin
IDEAYA Biosciences, Inc. FCF Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-33.6%
FY2025
5-year range
-3592.0% / 281.3%
FY2021-FY2025
Trend
+99.1%
vs FY2024
Sector context
#78 of 133
Health Care
What the data says
At -33.6%, IDEAYA Biosciences, Inc.'s fcf margin ranks #78 of 133 in the Health Care sector. FCF Margin returned to growth in FY2025 after 2 years of decline, reaching -33.6%.
Based on SEC 10-K filings.
-33.6% in FY2025 with a 5-year CAGR of +116.5%.
Improved from -502.9% to -33.6% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -314.9pp
- 5-Year Change
- +116.5pp
- 10-Year Change
- -
Sector benchmark
#78 of 133 in Health CareTop 59% of 133This company -33.6% Sector average -632.8%
▼
+94.7% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 99.1% year-over-year.
- Currently 599.3pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -33.6% | +99.1% |
| FY2024 | -3592.0% | -614.3% |
| FY2023 | -502.9% | -278.7% |
| FY2022 | 281.3% | - |
| FY2021 | - | - |
| FY2020 | -150.1% | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026